Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MVA BN RSV vaccine - Bavarian Nordic

Next Previous
X
Search
Drug Profile

MVA BN RSV vaccine - Bavarian Nordic

Alternative Names: Modified vaccinia ankara Bavarian Nordic respiratory syncytial virus vaccine; MVA-BN® RSV; MVA-mBN294B; Respiratory syncytial virus vaccine - Bavarian Nordic; RSV-vaccine-Bavarian-Nordic

Latest Information Update: 25 Jul 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bavarian Nordic
  • Class Respiratory syncytial virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Respiratory syncytial virus infections

Most Recent Events

  • 22 Jul 2023 Bavarian Nordic terminates its licence with Nuance Pharma for MVA BN RSV vaccine in Chinese Mainland, Hong Kong, Macau, Taiwan, South Korea and Southeast Asia
  • 22 Jul 2023 Discontinued - Phase-II for Respiratory syncytial virus infections (Prevention) in United Kingdom (IM)
  • 22 Jul 2023 Discontinued - Phase-II for Respiratory syncytial virus infections (Prevention, In adults) in Belgium (IM)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top